Patients receiving lithium therapy have a reduced prevalence of neurological and cardiovascular disorders

A variety of evidence from laboratory and animal studies suggests that lithium has neurotrophic and cytoprotective properties, and may ameliorate or prevent some disease states. We investigated whether such a protective effect can be observed in human psychiatric patients receiving lithium therapy....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Progress in neuro-psychopharmacology & biological psychiatry 2016-11, Vol.71, p.39-44
Hauptverfasser:	Prosser, James M., Fieve, Ronald R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Amyotrophic lateral sclerosis Cardiovascular Diseases - epidemiology Cardiovascular Diseases - prevention & control Dementia Female Humans Lithium Lithium Compounds - adverse effects Lithium Compounds - therapeutic use Male Middle Aged Myocardial infarction Nervous System Diseases - epidemiology Nervous System Diseases - prevention & control New York City - epidemiology Odds Ratio Outpatients Prevalence Retrospective Studies Seizures Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!